Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field
The Journal of Immunology · 01.10.2026 · 215 (10)
DOI: 10.1093/jimmun/vkag249 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 09.10.2026. Verfasst von Yulia Nefedova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ellen and Ronald Caplan Cancer Center, Wistar Institute, Philadelphia, PA, United States. Hauptthemen laut MEDLINE: Myeloid-Derived Suppressor Cells, Hematologic Neoplasms. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Myeloid-derived suppressor cells are a pivotal component of the immunosuppressive tumor microenvironment in hematologic malignancies. Through diverse mechanisms, they promote disease progression, therapeutic resistance, and immune evasion. This comprehensive review synthesizes current evidence on the roles of myeloid-derived suppressor cells across major hematologic cancers and evaluates their prognostic significance, highlighting implications for patient stratification and potential therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ellen and Ronald Caplan Cancer Center, Wistar Institute, Philadelphia, PA, United States.
- ICC, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Nefedova, Y., & Gabrilovich, D. I. (2026). Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field. The Journal of Immunology, 215(10). https://doi.org/10.1093/jimmun/vkag249
Vancouver
Nefedova Y, Gabrilovich DI. Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field. The Journal of Immunology. 2026;215(10). doi:10.1093/jimmun/vkag249
BibTeX
@article{Nefedova2026,
author = {Nefedova, Yulia and Gabrilovich, Dmitry I},
title = {Myeloid-derived suppressor cells in hematologic malignancies: A current state of the field},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {10},
doi = {10.1093/jimmun/vkag249}
}
EUVIMED